Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug-Eluting-Stent Market Penetration At Nadir? Rebound Forecast At TCT

This article was originally published in The Gray Sheet

Executive Summary

U.S. drug-eluting-stent market penetration reached an all-time low in September, but clinicians meeting last week in Washington, D.C., are confident new data will help to reverse the trend that began just over a year ago

You may also be interested in...



Looking Off-Label: Drug-Eluting Stents Versus Surgery And Bare-Metal

Two registry studies reported last week assess outcomes from drug-eluting stent procedures in patients with conditions that are not approved indications for the device. In one, the stents did not match the outcomes of open-heart surgery, but in the other the devices outpeformed their bare-metal cousins

Looking Off-Label: Drug-Eluting Stents Versus Surgery And Bare-Metal

Two registry studies reported last week assess outcomes from drug-eluting stent procedures in patients with conditions that are not approved indications for the device. In one, the stents did not match the outcomes of open-heart surgery, but in the other the devices outpeformed their bare-metal cousins

Device Firms Go Direct To Consumers Amid Physician Skepticism

Device firms are increasing investments in television advertising for their implantable products, but some physicians are skeptical that safety information about complex devices can be adequately conveyed in direct-to-consumer ads

Related Content

UsernamePublicRestriction

Register

MT025419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel